{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:18:25Z","timestamp":1790774305629,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003193","name":"Ministerstvo \u0161kolstva vedy v\u00fdskumu a \u0161portu Slovenskej republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003193","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.diabres.2021.108858","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T09:37:17Z","timestamp":1621330637000},"page":"108858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes"],"prefix":"10.1016","volume":"176","author":[{"given":"Alena","family":"Viktorinova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danica","family":"Malickova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Svitekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawkat","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Krizko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2021.108858_b0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s005920200037","article-title":"LDL-cholesterol\/apolipoprotein B ratio is a good predictor of LDL phenotype in type 2 diabetes","volume":"39","author":"Wagner","year":"2002","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabres.2021.108858_b0010","first-page":"2999","article-title":"The task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"37","author":"ESC\/EAS Guidelines for the Management of Dyslipidaemias","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.diabres.2021.108858_b0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pathol.2018.11.006","article-title":"Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment","volume":"51","author":"Carr","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.diabres.2021.108858_b0020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.atherosclerosis.2019.03.004","article-title":"Triglycerides and cardiovascular risk: apolipoprotein B holds the key","volume":"284","author":"Stock","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabres.2021.108858_b0025","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.amjcard.2017.01.008","article-title":"Usefulness of non-high-density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in diabetes mellitus","volume":"119","author":"Harari","year":"2017","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.diabres.2021.108858_b0030","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jacc.2019.04.047","article-title":"Trajectories of non\u2013HDL cholesterol across midlife","volume":"74","author":"Pencina","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.diabres.2021.108858_b0035","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1161\/ATVBAHA.116.307601","article-title":"Non-HDL cholesterol and triglycerides: implications for coronary atheroma progression and clinical events","volume":"36","author":"Puri","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.diabres.2021.108858_b0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48120-5","article-title":"Novel and traditional lipid profiles in Metabolic Syndrome reveal a high atherogenicity","volume":"9","author":"Paredes","year":"2019","journal-title":"Sci Rep"},{"issue":"22","key":"10.1016\/j.diabres.2021.108858_b0045","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1161\/CIRCULATIONAHA.104.532499","article-title":"Non\u2013high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men","volume":"112","author":"Pischon","year":"2005","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.diabres.2021.108858_b0050","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.2337\/diacare.26.7.2048","article-title":"Non-HDL cholesterol and apolipoprotein B in the dyslipidemic classification of type 2 diabetic patients","volume":"26","author":"Wagner","year":"2003","journal-title":"Diab Care"},{"issue":"5","key":"10.1016\/j.diabres.2021.108858_b0055","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1172\/JCI200417867","article-title":"Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions","volume":"114","author":"Renard","year":"2004","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.diabres.2021.108858_b0060","first-page":"595","article-title":"The atherogenic dyslipidemia complex and novel approaches to cardiovascular disease prevention in diabetes","volume":"34","author":"Stahel","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.diabres.2021.108858_b0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.atherosclerosis.2019.07.008","article-title":"Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: pooled analysis of nine ODYSSEY trials of alirocumab versus control","volume":"288","author":"Vallejo-Vaz","year":"2019","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.diabres.2021.108858_b0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.33549\/physiolres.933621","article-title":"Atherogenic impact of lecithin-cholesterol acyltransferase and its relation to cholesterol esterification rate in HDL (FERHDL) and AIP [log(TG\/HDL-C)] biomarkers: The butterfly effect?","volume":"66","author":"Dobiasova","year":"2017","journal-title":"Physiol Res"},{"issue":"2","key":"10.1016\/j.diabres.2021.108858_b0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacl.2010.02.005","article-title":"\u201cAtherogenic index of plasma\u201d (log10 triglyceride\/high-density lipoprotein\u2212cholesterol) predicts high blood pressure, diabetes, and vascular events","volume":"4","author":"Onat","year":"2010","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.diabres.2021.108858_b0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5551\/jat.12.67","article-title":"Measurement of small dense low-density lipoprotein particles","volume":"12","author":"Hirano","year":"2005","journal-title":"JAT"},{"issue":"6","key":"10.1016\/j.diabres.2021.108858_b0085","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1536\/ihj.52.343","article-title":"Low-density lipoprotein cholesterol\/apolipoprotein B ratio may be a useful index that differs in statin-treated patients with and without coronary artery disease: a case control study","volume":"52","author":"Tani","year":"2011","journal-title":"Int Heart J"},{"key":"10.1016\/j.diabres.2021.108858_b0090","first-page":"S1","article-title":"Standard of medical care in diabetes","volume":"42","author":"American Diabetes Association","year":"2019","journal-title":"Diab Care"},{"issue":"2","key":"10.1016\/j.diabres.2021.108858_b0095","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0003-2697(91)90010-Q","article-title":"Iodometric measurement of lipid hydroperoxides in human plasma","volume":"193","author":"Cramer","year":"1991","journal-title":"Anal Biochem"},{"issue":"4","key":"10.1016\/j.diabres.2021.108858_b0100","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-2275(20)38354-1","article-title":"A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent.","volume":"30","author":"el-Saadani","year":"1989","journal-title":"J Lipid Res"},{"key":"10.1016\/j.diabres.2021.108858_b0105","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/ATVBAHA.114.303284","article-title":"Small dense LDL cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study","volume":"34","author":"Hoogeveen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.diabres.2021.108858_b0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/13813455.2016.1195411","article-title":"Usefulness of the LDL-C\/apoB ratio in the overall evaluation of atherogenicity of lipid profile","volume":"123","author":"Kaneva","year":"2017","journal-title":"Arch Physiol Biochem"},{"issue":"3","key":"10.1016\/j.diabres.2021.108858_b0115","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/01.ATV.0000154144.73236.f4","article-title":"Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the qu\u00e9bec cardiovascular study","volume":"25","author":"St-Pierre","year":"2005","journal-title":"ATVB"},{"issue":"1","key":"10.1016\/j.diabres.2021.108858_b0120","doi-asserted-by":"crossref","DOI":"10.1186\/s12986-019-0334-y","article-title":"Small dense LDL cholesterol is associated with metabolic syndrome traits independently of obesity and inflammation","volume":"16","author":"Fan","year":"2019","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.diabres.2021.108858_b0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jacl.2011.02.001","article-title":"Clinical implications of discordance between LDL cholesterol and LDL particle number","volume":"5","author":"Otvos","year":"2011","journal-title":"J Clin Lipidol."},{"key":"10.1016\/j.diabres.2021.108858_b0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1373\/clinchem.2010.149559","article-title":"Development of a homogeneous assay for measurement of small dense LDL cholesterol","volume":"57","author":"Ito","year":"2011","journal-title":"Clin Chem."},{"issue":"11","key":"10.1016\/j.diabres.2021.108858_b0135","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.amjcard.2009.07.021","article-title":"Relation among lipoprotein subfractions and carotid atherosclerosis in Alaskan Eskimos (from the GOCADAN study)","volume":"104","author":"Masulli","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diabres.2021.108858_b0140","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/ATVBAHA.119.312336","article-title":"Elevated serum non-HDL (high-density lipoprotein) cholesterol and triglyceride levels as residual risk for myocardial infarction recurrence under statin treatment","volume":"39","author":"Suzuki","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.diabres.2021.108858_b0145","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-017-0606-7","article-title":"Relation between low-density lipoprotein cholesterol\/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study","volume":"16","author":"Tani","year":"2017","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.diabres.2021.108858_b0150","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.atherosclerosis.2014.05.914","article-title":"Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets","volume":"235","author":"Toth","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabres.2021.108858_b0155","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijcard.2018.03.128","article-title":"LDL particle size and composition and incident cardiovascular disease in a South-European population: the Hortega-Liposcale follow-up study","volume":"264","author":"Pichler","year":"2018","journal-title":"Int J Cardiol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721002175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721002175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:17:15Z","timestamp":1759173435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822721002175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":31,"alternative-id":["S0168822721002175"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108858","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108858"}}